First lady to showcase fresh-food offering at Chicago-area Walgreens
CHICAGO — First Lady Michelle Obama will be visiting with mayors from 10 U.S. cities on Oct. 25 at a Chicago-area Walgreens, according to published reports.
First Lady Obama, along with Chicago mayor Rahm Emanuel, will be discussing her "Let’s Move" campaign to reduce the incidence of childhood obesity.
The Walgreens hosting the First Lady has been expanded with a fresh food assortment as part of that chain’s 1,000-store pledge to alleviate urban food deserts. The locations offer more than 750 new food items, including fresh fruits and vegetables, frozen meats and fish, pasta, rice, beans, eggs, whole grain cereals and other healthy meal components.
BioPlus Specialty Pharmacy releases informational video
ALTAMONTE SPRINGS, Fla. — BioPlus Specialty Pharmacy has released a new video detailing the company’s operations and introducing company executives.BioPlus announced the release of a seven-minute video that includes one-on-one interviews with key executives, graphics, clips and commentary that discuss the company’s origins, its growth, use of technology and training and how it works with patients, physicians, the drug industry and payers.
"With our 20-year history, BioPlus has an important story to share," BioPlus president and CEO Stephen Vogt said. "We want viewers to know that we aren’t just a company dispensing medications; we treat each patient with an individual pharmaceutical care plan to make sure that their biologic specialty medicines have the intended results."
Insight Pharmaceuticals voluntarily recalls one lot of Nostrilla
LANGHORNE, Pa. — Insight Pharmaceuticals is voluntarily recalling one lot of a nasal decongestant due to the possibility of bacterial contamination, the company said.
Insight said it would recall lot number 11G075, UPC code 6373673005, of Nostrilla nasal spray to the consumer level because of possible contamination with Burkholderia cepacia bacteria. The lot, which contains 34,092 bottles, was distributed nationwide to retail outlets.
“It is our commitment to our customers to provide them with products they can rely on as safe and effective for their [Food and Drug Administration]-approved uses,” Insight CEO Gary Downing said. “Through our standard testing procedures and protocols, we discovered the potential presence of a bacterial contaminant in one lot of Nostrilla and reported it to the FDA. Consumer safety is our No. 1 priority, and we’ll take all necessary action to ensure Nostrilla, as well as all of our products, comply with FDA regulations and requirements."
Burkholderia cepacia can cause serious infections in people with compromised immune systems or chronic lung conditions, though the possibility of infection is remote in healthy people, the drug maker said, and no illnesses have been reported to date in connection with the recalled lot.